53 results
6-K
EX-99.1
BLRX
BioLineRx Ltd.
19 Aug 24
Notice of Annual General Meeting of Shareholders
4:30pm
26, 2024 (the “2023 Form 20-F”). Additional information regarding our Board of Directors, its committees and our corporate governance practices may
20-F/A
2023 FY
BLRX
BioLineRx Ltd.
26 Mar 24
Annual report (foreign) (amended)
4:57pm
growing our company.
Increasing scrutiny of, and evolving expectations for, sustainability and environmental, social, and governance, or ESG … country corporate governance practices instead of applicable SEC and Nasdaq requirements, which may result in less protection than is accorded to investors
6-K
EX-99
BLRX
BioLineRx Ltd.
27 May 22
2022 Annual General Meeting of Shareholders
4:30pm
Components of Compensation
A-7
2.6.
Motivation and Retention
A-7
Corporate Governance
A-8
3.1.
Compensation Committee Membership and Duties
A-8
3.2 … in a specific manner the motivation and retention of employees.
A - 7
BioLineRx Compensation Policy for Executive and Directors
Corporate Governance
3.1
424B5
zgdcw n6s51
21 Jan 21
Prospectus supplement for primary offering
4:31pm
424B5
j2mpb6panulcld2tzk
19 Jan 21
Prospectus supplement for primary offering
5:00pm
6-K
EX-1
hkvc8q8p37x
28 May 19
Current report (foreign)
7:04am
6-K
EX-10.2
lut2xjx4i4
3 Oct 18
BioLineRx Increases Stake in BL-8040, its Lead Oncology
6:03am